Browse 1,747 esophageal cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.
There are two main types of esophageal cancer, and in the United States the more common one is now adenocarcinoma, linked to long term acid reflux and a condition called Barrett's esophagus. Because the esophagus stretches easily, symptoms such as trouble swallowing often appear only after the cancer has grown. Outcomes improve most when cancer is found early and treated with combinations, and trials are testing immunotherapy, targeted drugs, and better ways to spot cancer in people with Barrett's esophagus before it develops.
A Study to Investigate the Safety and Efficacy of KQB368 as Monotherapy in Participants With Advanced Solid Malignancies
for
Advanced Solid Tumors, Colorectal Cancer (CRC),
Location: Boston MA, New York NY, Hackensack NJ, Philadelphia PA,
Sponsor: Kumquat Biosciences Inc.
Sex: All
Age: 18+
Code: NCT07542704
Phase 1, Recruiting
New
Multitargeted Recombinant Ad5 PSA/MUC-1/Brachyury-Based Immunotherapy (TriAdeno) Vaccine With IL-15 Superagonist N-803 in Participants With Clinically Localized Prostate Cancer Undergoing Active Surveillance
A Study to Test Different Doses of BI 3968621 When Given Alone or With Ezabenlimab in Patients With Advanced Cancer
for
Advanced Solid Tumour
Location: Sarasota FL, Nashville TN
Sponsor: Boehringer Ingelheim
Sex: All
Age: 18+
Code: NCT07851103
Phase 1, Recruiting
New
A Study of Freeze-Dried Miracle Fruit (MiraBurst) on Participants Receiving Cancer Treatment
for
Dysgeusia, Solid Tumor
Location: Cleveland OH
Sponsor: Case Comprehensive Cancer Center
Sex: All
Age: 18+
Code: NCT07419581
Recruiting
New
Chatbot Utilization for Pedigree Creation and Cancer Risk Assessment in Cancer Genetic Counseling
for
Hereditary Breast Carcinoma, Hereditary Malignant Neoplasm
Location: Buffalo NY
Sponsor: Roswell Park Cancer Institute
Sex: All
Age: 18+
Code: NCT07887620
Recruiting
New
A Single Arm Phase II Trial in p16-positive Oropharynx Cancer of Selective Dose De-escalation of nodAl VolumEs at Minimal Risk and Primary Site Disease (SAVED)
for
Head and Neck Cancer, Head and Neck Squamous Cell Cancer,
Location: Glen Burnie MD, Baltimore MD, Columbia MD
Sponsor: University of Maryland, Baltimore
Sex: All
Age: 18+
Code: NCT07418034
Phase 2, Recruiting
New
Facial Expression Awareness Training to Understand and Recognize Emotions
for
Survivors of Pediatric Brain Tumors, Pediatric Cancer
Location: Philadelphia PA
Sponsor: Children's Hospital of Philadelphia
Sex: All
Age: 6 - 13
Code: NCT07923370
Recruiting
New
Tele-HOPE: A Telehealth Pharmacist Opioid Patient Education Pilot Study
for
Hematopoietic and Lymphatic System Neoplasm,
Location: Seattle WA
Sponsor: Fred Hutchinson Cancer Center
Sex: All
Age: 18+
Code: NCT07737314
Recruiting
New
IgG Binding Protein LT in Support of a Healthy Gut on the Go
for
Gut Health, Gastrointestinal Symptoms, Safety in Healthy Adults
Location: Los Angeles CA
Sponsor: Bactolife A/S
Sex: All
Age: 18 - 70
Code: NCT07873957
Recruiting
New
Study Evaluating the Safety and Feasibility of Panitumumab-IRDye800 and [18F]NOTA-ABY-030 for Targeted Dual-Modality Imaging (TDMI) in Head and Neck Squamous Cell Carcinoma
for
HNSCC,Larynx, Pharynx and Oral Cavity, Squamous Cell Carcinoma,